Table 3.
Clinical characteristics and outcomes: comparison of patients with and without asthma (n = 473)
|
Characteristic |
Patients with asthma |
Patients without asthma |
P-Value* |
|---|---|---|---|
| No. (%) (n = 137) | No. (%) (n = 336) | ||
| Tachypnea |
60/137 (44) |
110/336 (33) |
0.07 |
| Tachycardia |
88/137 (64) |
213/336 (63) |
0.86 |
| Intensive care unit admission |
37/133 (28) |
108/321 (34) |
0.31 |
| Mechanical ventilation |
16/127 (13) |
69/301 (23) |
0.02 |
| Acute respiratory distress syndrome |
9/129 (7) |
38/292 (13) |
0.10 |
| Sepsis syndrome |
7/128 (6) |
31/291 (11) |
0.12 |
| Death |
5/137 (4) |
32/332 (10) |
0.04 |
| Influenza antiviral agent receipt |
|
|
|
| Any during hospitalization |
101/137 (74) |
270/336 (80) |
0.15 |
| ≤ 2 days of illness onset |
49/99 (50) |
106/269 (39) |
0.10 |
| ≤ 2 days of admission |
79/92 (86) |
219/253 (87) |
0.87 |
| Median days from illness onset to antiviral initiation (range) |
3 (0 – 18) |
3 (0 – 32) |
0.06 |
| Other treatment |
|
|
|
| Antibiotics |
101/137 (74) |
260/336 (77) |
0.40 |
| Steroids | 83/137 (61) | 96/336 (29) | <0.01 |
*P-Values stratified by age-group.